TP53 and neoplasm: Other commonly mutated genes with study-dependent prevalence rates include tumor-suppressor genes CDKN2A (49–98%), TP53 (20–76%) and SMAD4 (19–50%), along with many other gene alterations detected at a lower prevalence [8,9].